Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders
作者： Karen L. Cheal , Susan E. Alters , Aaron B. Kantor
DOI:
关键词:
摘要: Novel biological markers indicative of the action an anti-inflammatory or immunosuppressive drug can be used to evaluate efficacy and compare local systemic effects. They also aid in comparison different drugs, doses, delivery routes. The include cell populations, surface antigen expression levels, soluble factor concentrations. Measurement values novel biomarkers were shown change significantly allergic, atopic asthmatic, healthy subjects after administration prednisone.
lens.org 参考文章(6)
Mark W. Moore, Caroline A. Hebert, Rhona C. Kabakoff, Anti-IL-8 monoclonal antibodies for treatment of asthma ,(1995)
Peter C. Dau, James P. Callahan, Immune Modulation during Treatment of Systemic Sclerosis with Plasmapheresis and Immunosuppressive Drugs Clinical Immunology and Immunopathology. ,vol. 70, pp. 159- 165 ,(1994) , 10.1006/CLIN.1994.1024
Peter Joseph Schatz, Derek Dean Sloan, Min-Jia Chen, Ronald William Barrett, Bruce Padon England, Peptides and compounds that bind to the il-5 receptor ,(1995)
Roy C. Levitt, Steve Jones, Nicholas C. Nicolaides, William A. Kinney, Asthma associated factors as targets for treating atopic allergies including asthma and related disorders ,(2000)
Julio C. Fernandes, Dragan Jovanovic, Tony Ricketts, Jean Pierre Pelletier, Johanne Martel-Pelletier, John P. Caron, The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers. The Journal of Rheumatology. ,vol. 24, pp. 916- 925 ,(1997)